Innovis Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	$365K	Hold	5,221	–	–	0.14%	83
2023 Q2	$375K	Sell	5,221 -5,433	-51%	-$390K	0.14%	94
2023 Q1	$657K	Buy	10,654 +3,441	+48%	+$212K	0.27%	65
2022 Q4	$556K	Buy	+7,213	New	+$556K	0.25%	70